Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT07408024 · RECRUITING

Trial details

NCT number: NCT07408024
Sponsor: Toll Biotech Co. Ltd. (Beijing)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)

Start date: 2025-09-10
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.